Therapeutics , Targets , and Chemical Biology Histone Deacetylase Inhibitor AR-42 Differentially Affects Cell-cycle Transit in Meningeal and Meningioma Cells , Potently Inhibiting NF 2-De fi cient Meningioma Growth